Pharmacokinetics of eribulin mesylate in cancer patients with normal and impaired renal function.

Cancer Chemother Pharmacol · 2015 · PMC4612322 · PMID 26433580

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

The linear correlation between the degree of renal impairment (CrCl) and eribulin clearance (CL tot ) showed a positive trend, but the correlation was not significant and the slope was numerically small.

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.